Skip to main content
Erschienen in: Supportive Care in Cancer 6/2009

01.06.2009 | Supportive Care International

Symptom-monitoring behaviors of rural cancer patients and survivors

verfasst von: Carol J. Hermansen-Kobulnicky

Erschienen in: Supportive Care in Cancer | Ausgabe 6/2009

Einloggen, um Zugang zu erhalten

Abstract

Goals of work

Symptom monitoring is described among rural cancer patients and survivors with comparison across study variables.

Materials and methods

An anonymous survey was mailed to adult cancer patients and survivors. Sampling was via a cancer center serving a region of a US rural-frontier state. Symptom monitoring was measured as keeping written track of symptoms, side effects, trends in how one is feeling, and/or limits to what one can do.

Main results

Useable response rate was 60.4% (134/222). Respondents were on average 62.3 years old, 53.0% were female, and 52.3% had earned less than a college degree. Breast (30.6%) and prostate (28.4%) cancers were most common. Symptom monitoring was reported and confirmed via tracking means, by 32.1% of respondents. Symptom monitoring was associated with “shared” or “passive” symptom management decisions, keeping written track of questions to ask providers and answers received, report of fatigue, and having received the suggestion or advice on how to monitor. Symptom monitoring was not associated with age, education, sex, number of symptoms, or being given something with which to monitor.

Conclusions

Symptom monitoring apart from intervention appears common among rural cancer patients and survivors. Findings support using multi-dimensional ways to inquire of, and refer to, such behavior. Data show symptom monitoring is more common among those suffering cancer-related fatigue, indicating opportunities for intervention to optimize monitoring for improved outcomes. Findings also suggest symptom-monitoring patients may rely on, or interact more with, providers regarding symptom management.
Literatur
1.
Zurück zum Zitat Ajzen I, Fishbein M (1980) Understanding attitudes and predicting social behavior. Prentice Hall, Englewood Cliffs, NJ Ajzen I, Fishbein M (1980) Understanding attitudes and predicting social behavior. Prentice Hall, Englewood Cliffs, NJ
3.
Zurück zum Zitat Basch E, Artz D, Iasonos A, Speakman J, Shannon K et al (2007) Evaluation of an online platform for cancer patient self-reporting of chemotherapy toxicities. J Am Med Inform Assoc 14:264–268 doi:10.1197/jamia.M2177 PubMedCrossRef Basch E, Artz D, Iasonos A, Speakman J, Shannon K et al (2007) Evaluation of an online platform for cancer patient self-reporting of chemotherapy toxicities. J Am Med Inform Assoc 14:264–268 doi:10.​1197/​jamia.​M2177 PubMedCrossRef
4.
Zurück zum Zitat Bilodeau BA, Degner LF (1996) Information needs, sources of information, and decisional roles in women with breast cancer. Oncol Nurs Forum 23:691–696PubMed Bilodeau BA, Degner LF (1996) Information needs, sources of information, and decisional roles in women with breast cancer. Oncol Nurs Forum 23:691–696PubMed
7.
Zurück zum Zitat Cassileth BR, Zupkis RV, Sutton-Smith K, March V (1980) Information and participation preferences among cancer patients. Ann Intern Med 92:832–836PubMed Cassileth BR, Zupkis RV, Sutton-Smith K, March V (1980) Information and participation preferences among cancer patients. Ann Intern Med 92:832–836PubMed
10.
Zurück zum Zitat Desch CE, Smith TJ, Breindel CL (1992) Cancer treatment in rural areas. Hosp Health Serv Adm 37:449–463PubMed Desch CE, Smith TJ, Breindel CL (1992) Cancer treatment in rural areas. Hosp Health Serv Adm 37:449–463PubMed
11.
Zurück zum Zitat Dillman DA (1999) Mail and internet surveys: the tailored design method, vol. 2. Wiley, New York Dillman DA (1999) Mail and internet surveys: the tailored design method, vol. 2. Wiley, New York
16.
Zurück zum Zitat Hack TF, Degner LF, Dyck DG (1994) Relationship between preferences for decisional control and illness information among women with breast cancer: a quantitative and qualitative analysis. Soc Sci Med 39:279–289 doi:10.1016/0277-9536(94)90336-0 PubMedCrossRef Hack TF, Degner LF, Dyck DG (1994) Relationship between preferences for decisional control and illness information among women with breast cancer: a quantitative and qualitative analysis. Soc Sci Med 39:279–289 doi:10.​1016/​0277-9536(94)90336-0 PubMedCrossRef
17.
Zurück zum Zitat Harris KA (1998) The informational needs of patients with cancer and their families. Cancer Prac 6(1):39–46CrossRef Harris KA (1998) The informational needs of patients with cancer and their families. Cancer Prac 6(1):39–46CrossRef
22.
Zurück zum Zitat Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ (2007) Cancer statistics, 2007. CA Cancer J Clin 57:43–66PubMedCrossRef Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ (2007) Cancer statistics, 2007. CA Cancer J Clin 57:43–66PubMedCrossRef
25.
Zurück zum Zitat Johnson JE, Fieler VK, Jones LS, Wlasowicz GS, Mitchell ML (1997) Self-regulation theory: applying theory to your practice. Oncology Nursing Press, Pittsburgh, PA Johnson JE, Fieler VK, Jones LS, Wlasowicz GS, Mitchell ML (1997) Self-regulation theory: applying theory to your practice. Oncology Nursing Press, Pittsburgh, PA
26.
Zurück zum Zitat Kearney N, Kidd L, Miller M et al (2006) Utilising handheld computers to monitor and support patients receiving chemotherapy: results of a UK-based feasibility study. Support Care Cancer 14:742–752 doi:10.1007/s00520-005-0002-9 PubMedCrossRef Kearney N, Kidd L, Miller M et al (2006) Utilising handheld computers to monitor and support patients receiving chemotherapy: results of a UK-based feasibility study. Support Care Cancer 14:742–752 doi:10.​1007/​s00520-005-0002-9 PubMedCrossRef
28.
Zurück zum Zitat Kroenke K, Spitzer RL (1998) Gender differences in the reporting of physical and somatoform symptoms. Psychosom Med 60:150–155PubMed Kroenke K, Spitzer RL (1998) Gender differences in the reporting of physical and somatoform symptoms. Psychosom Med 60:150–155PubMed
29.
Zurück zum Zitat Leventhal H, Leventhal E, Schaefer P (1991) Vigilant coping and health behavior. In: Ory M, Abeles R (eds) Aging, health, and behavior. Johns Hopkins, Baltimore, MD, pp 109–140 Leventhal H, Leventhal E, Schaefer P (1991) Vigilant coping and health behavior. In: Ory M, Abeles R (eds) Aging, health, and behavior. Johns Hopkins, Baltimore, MD, pp 109–140
30.
Zurück zum Zitat Leventhal H, Nerenz DR, Straus A (1980) Self-regulation and the mechanisms for symptom appraisal. In: Mechanic D (ed) Psychosocial epidemiology 3: symptoms, illness behavior, and help-seeking. Neale Watson, New York, pp 55–86 Leventhal H, Nerenz DR, Straus A (1980) Self-regulation and the mechanisms for symptom appraisal. In: Mechanic D (ed) Psychosocial epidemiology 3: symptoms, illness behavior, and help-seeking. Neale Watson, New York, pp 55–86
31.
Zurück zum Zitat Madan A, Borckardt J, Weinstein B, Wagner M, Dominick C et al (2008) Clinical outcomes assessment in behavioral healthcare: searching for practical solutions. J Healthc Qual 30(4):30–37PubMed Madan A, Borckardt J, Weinstein B, Wagner M, Dominick C et al (2008) Clinical outcomes assessment in behavioral healthcare: searching for practical solutions. J Healthc Qual 30(4):30–37PubMed
33.
Zurück zum Zitat Mullin SM, Fletcher DM, Tyler LS (1998) Mail-in questionnaire for monitoring nausea and vomiting in oncology outpatients. Am J Health Syst Pharm 55:1903–1906PubMed Mullin SM, Fletcher DM, Tyler LS (1998) Mail-in questionnaire for monitoring nausea and vomiting in oncology outpatients. Am J Health Syst Pharm 55:1903–1906PubMed
36.
Zurück zum Zitat Rowland D, Lyons B (1989) Triple jeopardy: rural, poor and uninsured. Health Serv Res 23:975–1004PubMed Rowland D, Lyons B (1989) Triple jeopardy: rural, poor and uninsured. Health Serv Res 23:975–1004PubMed
40.
Zurück zum Zitat Spirig R, Moody K, Battegay M, De Geest S (2005) Symptom management in HIV/AIDS: advancing the conceptualization. ANS Adv Nurs Sci 28(4):333–344PubMed Spirig R, Moody K, Battegay M, De Geest S (2005) Symptom management in HIV/AIDS: advancing the conceptualization. ANS Adv Nurs Sci 28(4):333–344PubMed
41.
Zurück zum Zitat Tucci RA, Bartels KL (1998) Patient use of the symptom reporting tool. Clin J Oncol Nurs 2(3):97–99PubMed Tucci RA, Bartels KL (1998) Patient use of the symptom reporting tool. Clin J Oncol Nurs 2(3):97–99PubMed
45.
Zurück zum Zitat Weinert C, Burman ME (1994) Rural health and health-seeking behaviors. Annu Rev Nurs Res 12:65–92PubMed Weinert C, Burman ME (1994) Rural health and health-seeking behaviors. Annu Rev Nurs Res 12:65–92PubMed
Metadaten
Titel
Symptom-monitoring behaviors of rural cancer patients and survivors
verfasst von
Carol J. Hermansen-Kobulnicky
Publikationsdatum
01.06.2009
Verlag
Springer-Verlag
Erschienen in
Supportive Care in Cancer / Ausgabe 6/2009
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-008-0552-8

Weitere Artikel der Ausgabe 6/2009

Supportive Care in Cancer 6/2009 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.